Victrex PLC (LSE:VCT) - Share price


Stock Report

Victrex PLC VCT

Last Price
GBX2,366.00

Day Change
-4.00|-0.17%

As of 12/11/2019
18:30:13 GMT | GBX
Minimum 15 Minutes Delay.

Last Close2,370.00p
Day Range2,334.00 - 2,384.00
Mkt Cap2.05Bil
52-Wk Range1,813.68 - 2,730.00
Yield %2.49
ISINGB0009292243
Volume267,255
P/E20.79
P/S0.06
P/CF0.16

Share Price

Total Returns 11/11/2019

 Chg (%)  
More ...
Victrex PLC10.96 
FTSE 100 TR GBP1.79
 
Financials
201620172018
More ...
Income Statement
Turnover252.30290.20326.00
Operating Profit100.80113.10126.90
Net Profit82.5099.50110.60
Reported EPS96.70116.20128.20
Balance Sheet
Current Assets174.80229.50257.60
Non Current Assets297.90308.60306.20
Total Assets472.70538.10563.80
Current Liabilities53.8041.3051.40
Total Liabilities---
Total Equity389.10478.40489.90
Cash Flow
Operating Cash Flow96.10137.40136.40
Net Change in Cash8.6056.70-49.20

Regulatory News

DateAuthor Headline
14/10/2019James Gard Top 20 FTSE Dividend Paying Stocks
UPDATED OCTOBER 2019: Imperial retains its top spot because its share price has weakened since the chief executive Alison Cooper announced her departure
25/01/2018David Brenchley Oil: A Once-in-a-Generation Investment Opportunity?
Contrarian fund managers are bullish on the outlook for oil companies. We run down the investment case and pick out a few stocks and funds to play the sector
19/01/2018David Brenchley These Stocks Have Doubled in Price - Is it Time to Sell?
One fund manager tells us he has more sell ideas than buys. Here he reveals three stocks whose valuations are looking stretched
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
16/10/2019PurchaseDr. Martin Court2,112.006127.00
16/09/2019PurchaseMr. Tim J Cooper2,272.005114.00
16/09/2019PurchaseDr. Martin Court2,272.005114.00
16/08/2019PurchaseMr. Tim J Cooper1,880.007132.00

Company Profile

Victrex PLC manufactures and sells high performance polymers and provides PEEK and PAEK polymer solutions. It operates in two segments namely, Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions).

Sector

Specialty Chemicals

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 05/12/2019

Final Results
Ratios
Comp
More ...
PER (E)19.10
Div Yld (E)2.71
PEG (E)7.01
ROCE24.88
Op Mrgn0.39
EPS Grwth0.08
Dividends
PreviousLatest
More ...
Record Date01/02/1907/06/19
Ex-Div31/01/1906/06/19
Paid22/02/1928/06/19
Amnt46.1413.42
Directors
More ...
Executive DirectorMr. Jakob Oskar Sigurdsson
Non-Executive DirectorDr. Pamela J Kirby
Non-Executive DirectorMr. Brendan Connolly
Non-Executive Director, ChairmanMr. Lawrence Craig Pentz
Non-Executive DirectorRichard J Armitage
Executive DirectorDr. Martin Court
Non-Executive DirectorMs. Jane Toogood
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.